Current Use and Developments Needed for Optimal Design in Pharmacometrics: A Study Performed Among DDMoRe's European Federation of Pharmaceutical Industries and Associations Members - Université Paris Cité Accéder directement au contenu
Article Dans Une Revue CPT: Pharmacometrics and Systems Pharmacology Année : 2013

Current Use and Developments Needed for Optimal Design in Pharmacometrics: A Study Performed Among DDMoRe's European Federation of Pharmaceutical Industries and Associations Members

Résumé

Methods and software tools for optimal design in nonlinear mixed effect models, based on the Fisher information matrix, have been developed for a decade. Academic groups regularly proposed new versions. Present tools do not incorporate adaptive designs for these models although prior information is needed and adaptive designs are increasingly used in drug development. We conducted a study among drug companies of the Drug and Disease Model Resources consortium to identify current practices and expectations.
Fichier principal
Vignette du fichier
93_1_merged_1362063075.pdf (190.09 Ko) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)
Loading...

Dates et versions

hal-01122163 , version 1 (03-03-2015)

Identifiants

Citer

France Mentré, Marylore Chenel, Emmanuelle Comets, Joachim Grevel, Andrew C. Hooker, et al.. Current Use and Developments Needed for Optimal Design in Pharmacometrics: A Study Performed Among DDMoRe's European Federation of Pharmaceutical Industries and Associations Members. CPT: Pharmacometrics and Systems Pharmacology, 2013, 2, pp.e46. ⟨10.1038/psp.2013.19⟩. ⟨hal-01122163⟩
500 Consultations
300 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More